Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Coagulation factors VII, IX and X are effective antibacterial proteins against drug-resistant Gram-negative bacteria.

Chen J, Li X, Li L, Zhang T, Zhang Q, Wu F, Wang D, Hu H, Tian C, Liao D, Zhao L, Song D, Zhao Y, Wu C, Song X.

Cell Res. 2019 Aug 9. doi: 10.1038/s41422-019-0202-3. [Epub ahead of print]

PMID:
31399697
2.

Identification potential inhibitors against the Streptococcus quorum-sensing signal pathway.

Long X, Zheng R, Liu M, Wu C, Bao J.

J Biomol Struct Dyn. 2019 Aug 14:1-11. doi: 10.1080/07391102.2019.1651674. [Epub ahead of print]

PMID:
31378148
3.

Screening of novel histone deacetylase 7 inhibitors through molecular docking followed by a combination of molecular dynamics simulations and ligand-based approach.

Yuan Y, Hu Z, Bao M, Sun R, Long X, Long L, Li J, Wu C, Bao J.

J Biomol Struct Dyn. 2019 Sep;37(15):4092-4103. doi: 10.1080/07391102.2018.1541141. Epub 2018 Dec 5.

PMID:
30417746
4.

Computer-aided identification of a novel pyruvate kinase M2 activator compound.

Li Y, Bao M, Yang C, Chen J, Zhou S, Sun R, Wu C, Li X, Bao J.

Cell Prolif. 2018 Dec;51(6):e12509. doi: 10.1111/cpr.12509. Epub 2018 Aug 21.

PMID:
30133040
5.
6.

Long noncoding RNA OCC-1 suppresses cell growth through destabilizing HuR protein in colorectal cancer.

Lan Y, Xiao X, He Z, Luo Y, Wu C, Li L, Song X.

Nucleic Acids Res. 2018 Jun 20;46(11):5809-5821. doi: 10.1093/nar/gky214.

7.

In silico identification of small molecules as novel LXR agonists for the treatment of cardiovascular disease and cancer.

Wang X, Lu K, Luo H, Liang D, Long X, Yuan Y, Wu C, Bao J.

J Mol Model. 2018 Feb 15;24(3):57. doi: 10.1007/s00894-018-3578-y.

PMID:
29450657
8.

CM-viewer: Visualizing interaction network of co-mutated and mutually exclusively mutated cancer genes.

Zhou N, Hu Z, Wu C, Bao J.

Biosystems. 2018 Apr;166:37-42. doi: 10.1016/j.biosystems.2017.12.009. Epub 2017 Dec 24.

PMID:
29278730
9.

Mutational signatures efficiently identify different mutational processes underlying cancers with similar somatic mutation spectra.

Zhou N, Yuan Y, Long X, Wu C, Bao J.

Mutat Res. 2017 Dec;806:27-30. doi: 10.1016/j.mrfmmm.2017.07.004. Epub 2017 Jul 19.

PMID:
28942182
10.

Ceramide synthase-4 orchestrates the cell proliferation and tumor growth of liver cancer in vitro and in vivo through the nuclear factor-κB signaling pathway.

Chen J, Li X, Ma D, Liu T, Tian P, Wu C.

Oncol Lett. 2017 Aug;14(2):1477-1483. doi: 10.3892/ol.2017.6365. Epub 2017 Jun 9.

11.

Discovery of a Potential HER2 Inhibitor from Natural Products for the Treatment of HER2-Positive Breast Cancer.

Li J, Wang H, Li J, Bao J, Wu C.

Int J Mol Sci. 2016 Jul 1;17(7). pii: E1055. doi: 10.3390/ijms17071055.

12.

Role of reactive oxygen species-mediated MAPK and NF-κB activation in polygonatum cyrtonema lectin-induced apoptosis and autophagy in human lung adenocarcinoma A549 cells.

Liu T, Wu L, Wang D, Wang H, Chen J, Yang C, Bao J, Wu C.

J Biochem. 2016 Dec;160(6):315-324. Epub 2016 Jun 18.

PMID:
27318358
13.

Polygonatum odoratum lectin induces apoptosis and autophagy by regulation of microRNA-1290 and microRNA-15a-3p in human lung adenocarcinoma A549 cells.

Wu L, Liu T, Xiao Y, Li X, Zhu Y, Zhao Y, Bao J, Wu C.

Int J Biol Macromol. 2016 Apr;85:217-26. doi: 10.1016/j.ijbiomac.2015.11.014. Epub 2015 Nov 10.

PMID:
26562549
14.

Human eukaryotic elongation factor 1A forms oligomers through specific cysteine residues.

Liu T, Yang Y, Wang D, Xiao Y, Du G, Wu L, Ding M, Li L, Wu C.

Acta Biochim Biophys Sin (Shanghai). 2015 Dec;47(12):1011-7. doi: 10.1093/abbs/gmv113. Epub 2015 Oct 28.

PMID:
26515794
15.

Discover natural compounds as potential phosphodiesterase-4B inhibitors via computational approaches.

Li J, Zhou N, Liu W, Li J, Feng Y, Wang X, Wu C, Bao J.

J Biomol Struct Dyn. 2016 May;34(5):1101-12. doi: 10.1080/07391102.2015.1070749. Epub 2016 Jan 20.

PMID:
26159554
16.

Conformational study reveals amino acid residues essential for hemagglutinating and anti-proliferative activities of Clematis montana lectin.

Lu B, Zhang B, Qi W, Zhu Y, Zhao Y, Zhou N, Sun R, Bao J, Wu C.

Acta Biochim Biophys Sin (Shanghai). 2014 Nov;46(11):923-34. doi: 10.1093/abbs/gmu085. Epub 2014 Sep 19.

PMID:
25239139
17.

In silico discovery of potential VEGFR-2 inhibitors from natural derivatives for anti-angiogenesis therapy.

Li J, Zhou N, Luo K, Zhang W, Li X, Wu C, Bao J.

Int J Mol Sci. 2014 Sep 11;15(9):15994-6011. doi: 10.3390/ijms150915994.

18.

p53 N‑terminal binding and stabilisation by PIAS3 inhibits MDM2‑induced p53 ubiquitination and regulates cell growth.

Zhao Z, Wu L, Shi H, Wu C.

Mol Med Rep. 2014 May;9(5):1903-8. doi: 10.3892/mmr.2014.1993. Epub 2014 Feb 27.

PMID:
24584189
19.

17β-Estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level.

Zhao Z, Chen C, Liu Y, Wu C.

Biochem Biophys Res Commun. 2014 Mar 7;445(2):388-93. doi: 10.1016/j.bbrc.2014.02.006. Epub 2014 Feb 10.

PMID:
24525122
20.

The RNA recognition motif domains of RBM5 are required for RNA binding and cancer cell proliferation inhibition.

Zhang L, Zhang Q, Yang Y, Wu C.

Biochem Biophys Res Commun. 2014 Feb 14;444(3):445-50. doi: 10.1016/j.bbrc.2014.01.102. Epub 2014 Jan 29.

PMID:
24486491

Supplemental Content

Loading ...
Support Center